bendazac has been researched along with Encephalopathy, Hepatic in 2 studies
bendazac : A monocarboxylic acid that is glycolic acid in which the hydrogen attached to the 2-hydroxy group is replaced by a 1-benzyl-1H-indazol-3-yl group. Although it has anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties and has been used for the treatment of various inflammatory skin disorders, its principal effect is to inhibit the denaturation of proteins. Its lysine salt is used in the management of cataracts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hermo, JA | 1 |
| Pineda, JR | 1 |
| Alfonsín, N | 1 |
| Rodríguez, A | 1 |
| Laporte, JR | 1 |
| Capellà, D | 1 |
2 other studies available for bendazac and Encephalopathy, Hepatic
| Article | Year |
|---|---|
[Fulminant liver failure due to bendazac].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Hepatic Encephalopathy; Humans; Indazoles | 1995 |
[Fulminant liver failure due to bendazac].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Hepatic Encephalopathy; Humans; Indazoles | 1995 |